Pattern of Statins Use in Catalonia
1 other identifier
observational
180,723
0 countries
N/A
Brief Summary
To describe the new statins prescription pattern in Catalonia (getting their first prescription for any statin, or receiving a change in their statin treatment including switching, changing in doses or adding ezetimibe/fibrates) since September 2009.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2012
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 18, 2011
CompletedFirst Posted
Study publicly available on registry
November 23, 2011
CompletedStudy Start
First participant enrolled
February 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2012
CompletedFebruary 22, 2012
February 1, 2012
Same day
November 18, 2011
February 20, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Description of detailed clinical treatment in terms of duration of treatment, doses, drug switches and add-on therapy, in patients with hypercholesterolemia and on treatment with statins from the index date.
From 1st September 2009 to 30th August 2010
Type of prescriber
Number of patient, whom the drug was prescribed by the specified type of prescriber (specialist, general practitioner, etc.)
From 1st September 2009 to 30th August 2010
Date of change from previous statin to new.
From 1st September 2009 to 30th August 2010
Secondary Outcomes (8)
Description of demographic data including: Sex, Age, Height (cm), Weight (kg), Smoking habits (packs-years), Alcohol consume habits (units/week), active worker or retired, Pregnancy.
From 1st September 2009 to 30th August 2010
Total cholesterol
From 1st September 2009 to 30th August 2010
Low Density Lipoprotein (LDL) cholesterol concentration
From 1st September 2009 to 30th August 2010
High Density Lipoproteins (HDL) cholesterol concentration
From 1st September 2009 to 30th August 2010
Triglicerides (TG) concentration
From 1st September 2009 to 30th August 2010
- +3 more secondary outcomes
Eligibility Criteria
Hypercolesterolemic patients in treatment with statins.
You may qualify if:
- Patient with a new prescription of statin Patients receiving one or more changes of the statins treatment
You may not qualify if:
- Patient with not full information
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- AstraZenecalead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 18, 2011
First Posted
November 23, 2011
Study Start
February 1, 2012
Primary Completion
February 1, 2012
Study Completion
February 1, 2012
Last Updated
February 22, 2012
Record last verified: 2012-02